Cytokinetics, Incorporated Total Non Current Liabilities 2011-2026 | CYTK

Annual Total Non Current Liabilities Cytokinetics, Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	275 M	163 M	153 M	42.5 M	15 M	17 M	2.04 M	361 K	3 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
275 M	3 K	74.1 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	2.21 M	$ 0.87	-0.11 %	$ 6.4 M	China
Aquestive Therapeutics AQST	90.3 M	$ 4.18	1.95 %	$ 447 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 9.76	1.77 %	$ 631 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	341 M	$ 96.92	-6.31 %	$ 27.2 B	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 21.99	-2.05 %	$ 3.64 B	USA
Cerus Corporation CERS	58.1 M	$ 2.89	42.45 %	$ 551 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	105 M	$ 1.44	-	$ 235 M	France
Dynavax Technologies Corporation DVAX	218 M	-	-	$ 2.02 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Editas Medicine EDIT	186 M	$ 2.88	-4.17 %	$ 256 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.97	-6.9 %	$ 4.89 M	Israel
Edesa Biotech EDSA	2.6 M	$ 18.1	-0.96 %	$ 57.9 M	USA
Eiger BioPharmaceuticals EIGR	31.9 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	5.24 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Evogene Ltd. EVGN	5.36 M	$ 0.8	2.56 %	$ 27.9 M	Israel
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada